Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Adagene (ADAG) Cash & Equivalents (2020 - 2025)

Historic Cash & Equivalents for Adagene (ADAG) over the last 6 years, with Q2 2025 value amounting to $85.2 million.

  • Adagene's Cash & Equivalents fell 1095.31% to $85.2 million in Q2 2025 from the same period last year, while for Jun 2025 it was $85.2 million, marking a year-over-year decrease of 1095.31%. This contributed to the annual value of $85.2 million for FY2024, which is 4073.78% down from last year.
  • As of Q2 2025, Adagene's Cash & Equivalents stood at $85.2 million, which was down 1095.31% from $85.2 million recorded in Q4 2024.
  • Adagene's 5-year Cash & Equivalents high stood at $208.3 million for Q2 2021, and its period low was $168.04 during Q2 2022.
  • Moreover, its 5-year median value for Cash & Equivalents was $109.9 million (2023), whereas its average is $116.2 million.
  • Its Cash & Equivalents has fluctuated over the past 5 years, first plummeted by 9999.99% in 2022, then skyrocketed by 8555246410.43% in 2023.
  • Quarter analysis of 5 years shows Adagene's Cash & Equivalents stood at $174.4 million in 2021, then decreased by 17.57% to $143.8 million in 2022, then decreased by 23.53% to $109.9 million in 2023, then dropped by 22.5% to $85.2 million in 2024, then changed by 0.0% to $85.2 million in 2025.
  • Its Cash & Equivalents stands at $85.2 million for Q2 2025, versus $85.2 million for Q4 2024 and $95.7 million for Q2 2024.